Biological dose-escalated definitive radiation therapy in head and neck cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biological dose-escalated definitive radiation therapy in head and neck cancer

Published:2017-04 Issue:1072 Volume:90 Page:20160477
ISSN:0007-1285
Container-title:The British Journal of Radiology
language:en
Short-container-title:BJR

Author:

Costa Ferreira Brigida¹²,Sá-Couto Pedro³,Khouri Leila⁴,Lopes Maria do Carmo⁵

Affiliation:

1. Department of Physics, Aveiro University, Aveiro, Portugal

2. School of Allied Health Technologies, Polytechnic of Porto, Porto, Portugal

3. Department of Mathematics, Center for Research and Development in Mathematics and Applications, Aveiro University, Aveiro, Portugal

4. Department of Radiation Therapy, Portuguese Oncology Institute of Coimbra Francisco Gentil (IPOCFG), Coimbra, Portugal

5. Department of Medical Physics, Portuguese Oncology Institute of Coimbra Francisco Gentil, Coimbra, Portugal

Publisher

British Institute of Radiology

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://www.birpublications.org/doi/pdf/10.1259/bjr.20160477

Reference22 articles.

1. Radiotherapy for cancer of the head and neck: altered fractionation regimens

2. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

3. Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer

4. Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review

5. Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study;BMC Cancer;2022-12-20

2. Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma – Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes;Frontiers in Oncology;2021-05-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3